Technical Analysis for ATXI - Avenue Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 6.59 1.54% 0.10
ATXI closed up 1.54 percent on Friday, January 18, 2019, on 1.38 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ATXI trend table...

Date Alert Name Type % Chg
Jan 18 New 52 Week Closing High Bullish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Above Upper BB Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 18 Up 5 Days in a Row Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%

Older signals for ATXI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Is ATXI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.62
52 Week Low 2.08
Average Volume 88,393
200-Day Moving Average 4.1088
50-Day Moving Average 5.1865
20-Day Moving Average 5.51
10-Day Moving Average 5.783
Average True Range 0.4377
ADX 28.92
+DI 28.1256
-DI 8.8725
Chandelier Exit (Long, 3 ATRs ) 5.3069
Chandelier Exit (Short, 3 ATRs ) 5.8131
Upper Bollinger Band 6.4515
Lower Bollinger Band 4.5685
Percent B (%b) 1.07
BandWidth 34.174229
MACD Line 0.346
MACD Signal Line 0.2306
MACD Histogram 0.1155
Fundamentals Value
Market Cap 66.17 Million
Num Shares 10 Million
EPS -0.44
Price-to-Earnings (P/E) Ratio -14.98
Price-to-Sales 0.00
Price-to-Book 1.57
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.15
Resistance 3 (R3) 7.08 6.84 7.05
Resistance 2 (R2) 6.84 6.70 6.87 7.02
Resistance 1 (R1) 6.71 6.61 6.78 6.78 6.99
Pivot Point 6.47 6.47 6.50 6.50 6.47
Support 1 (S1) 6.34 6.33 6.41 6.41 6.19
Support 2 (S2) 6.10 6.24 6.13 6.16
Support 3 (S3) 5.97 6.10 6.13
Support 4 (S4) 6.04